Acalabrutinib 100 mg Cap, Trametinib 0.5 mg Tab, Inj Evolocumab 140 mg, LDL cholestrol with calibrator
Indian Army · Pharmaceuticals · open
Key facts
- EMD: ₹1K
- Published: 11 Aug 2026
- Closing date: 22 Aug 2026
- Status: open
- Ministry: Ministry Of Defence
- Department: Department Of Military Affairs
Description
Tender for supply of specified pharmaceutical and diagnostic items including Acalabrutinib, Trametinib, Evolocumab, and related calibrators, with a total quantity of 581 units, bid validity of 180 days, and scheduled bid opening on 22-08-2026.
Eligibility & requirements
- Past performance: 50%
- Startup relaxation: Yes
- MSE relaxation: Yes
- Documents required: Experience Certificate, Turnover Certificate, OEM Authorization
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: Item wise evaluation
- Make in India (MII): Yes
- MSE preference: Yes
Line items (4)
- Acalabrutinib 100 mg Cap — Qty: 4 capsule
- Trametinib 0.5 mg Tab — Qty: 4 tablet
- Evolocumab 140 mg Inj — Qty: 1 inj
- LDL Cholestrol with calibrator — Qty: 2 set
1 tender document(s) available — sign up to download.